Disclosure and Transparency for Clinical Data Summit Philadelphia, Pennsylvania, USA 7-8 August 2017

Description:
Transparency of clinical trial information is evolving on a global and national scale. Pharmaceutical companies and academia are overwhelmed by new regulatory requirements, operational challenges and renewed infrastructure needs to disseminate clinical trial data compliantly. These organizations are challenged to meet the ever-changing regulatory standards made by The Final Rule and EMA Policy 0070 of current, past and future clinical trials, but are struggling to establish compliant data transparency without universal regulations, standardized processes or regulatory support.

The Disclosure and Transparency for Clinical Data Summit convenes industry professionals to examine the global and national legislative landscape of data disclosure and transparency. The expert speaking faculty will determine the required internal infrastructure, resources and best practices to disclose transparent data that balances commercial and ethical responsibilities. Case studies will outline how to harmonize and standardize the execution of clinical trial data disclosure that meets federal and global criteria.

Prices:
Conference Only (Early Bird Pricing) — Register before June 23, 2017: USD 1895
Conference Only (Standard Pricing) — Register after June 23, 2017: USD 2095

Speakers: René Allard, Public Disclosure Lead, GRÜNENTHAL GMBH; Bhanu Bahl, Ph.D., Director, Clinical and Translational Science Center